2002 Clinical Trials Concentrates Treatment 
The Cannigma
AUGUST 14, 2022
A flow state is when all of your attention is concentrated on the task at hand, to the point that the world outside flows away. A 2002 study found that cannabis increases blood flow to the frontal lobe of the brain. Being focused is not the same thing as being in a flow state. Focus is like a spotlight you shine on a task.
The Cannigma
DECEMBER 12, 2022
Scientists are hopeful that psychedelics might have more of a curative effect when it comes to mental health than many existing treatment options; meaning that unlike most psychiatric medications, psychedelics may be able to prompt long-term changes to our mental state with only a few doses. Are psychedelics safe?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Green Relief
MAY 13, 2018
The benefits of CBD-rich cannabis concentrates for chronic traumatic encephalopathy (CTE) are well-known among football players and other pro athletes. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. But the U.S. BY MARTIN A.
Green Relief
MAY 12, 2018
The benefits of CBD-rich cannabis concentrates for chronic traumatic encephalopathy (CTE) are well-known among football players and other pro athletes. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. But the U.S. BY MARTIN A.
Cannabis Law Report
NOVEMBER 24, 2021
Its use in China, Tibet, India, Nepal, Japan (McPartland and Hegman 2018 , Touw 1981 ), Ancient Greece and Rome (Butrica 2002 ), and Iran, Iraq, Turkey, Syria, and the Balkans (McPartland and Hegman 2018 ; Lozano 1997 ; Aldrich 1997 ) goes back thousands of years. Bonini et al.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Lancet Neurol Dec 23 2015.
Expert insights. Personalized for you.
118 
Let's personalize your content